Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07171567

Vacuum Therapy for the Treatment of Penile Numbness/Sensory Changes

Status
Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
8 (estimated)
Sponsor
Ottawa Hospital Research Institute · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, uncontrolled, Hypothesis generating study. A total of eight adult male participants experiencing penile insensitivity will be recruited through the Ottawa Hospital's Men's Health Clinic. Participants will receive a Health Canada Class I VED to use daily over a six-month period. The study includes biweekly check-ins and monthly questionnaire assessments (including the IIEF-5 and two custom instruments focused on penile sensitivity) administered via Lime Survey. The primary outcome is to explore the feasibility and acceptability of daily vacuum erection device (VED) therapy over a 6-month period in adult males experiencing penile numbness/insensitivity. Data analysis will focus on feasibility metrics (e.g., adherence rates, completion of assessments) and descriptive statistics. Any changes in questionnaire scores over time will be evaluated using within-subject comparisons (e.g., Wilcoxon signed-rank test), recognizing that findings are preliminary and not generalizable due to the lack of a control group.

Conditions

Interventions

TypeNameDescription
DEVICEVacuum erection deviceA vacuum erection device (VED) is a mechanical device designed to enhance blood flow to the corpora cavernosa by creating a vacuum environment. When combined with a constriction ring at the base of the penis, VEDs can promote and sustain an erection. This is a prospective, uncontrolled, hypothesis-generating pilot study. Eight adult male participants with penile insensitivity will be enrolled and asked to use a VED daily for six months. Monthly self-reported questionnaire data and biweekly follow-up calls will be used to assess feasibility and to collect exploratory outcome data.

Timeline

Start date
2025-10-01
Primary completion
2027-10-01
Completion
2027-10-01
First posted
2025-09-12
Last updated
2025-09-12

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT07171567. Inclusion in this directory is not an endorsement.